You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson

Last Updated: July 12, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Ataciguat

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Ataciguat?

Ataciguat is an investigational drug.

There have been 4 clinical trials for Ataciguat. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2015.

The most common disease conditions in clinical trials are Constriction, Pathologic, Aortic Valve Stenosis, and Neuralgia. The leading clinical trial sponsors are Sanofi, Sanofi-Synthelabo, and National Center for Research Resources (NCRR).

Recent Clinical Trials for Ataciguat
A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve CalcificationNational Institutes of Health (NIH)Phase 2
A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve CalcificationSanofiPhase 2
A Study Evaluating the Effects of Ataciguat (HMR1766) on Aortic Valve CalcificationMayo ClinicPhase 2

See all Ataciguat clinical trials

Clinical Trial Summary for Ataciguat

Top disease conditions for Ataciguat
Top clinical trial sponsors for Ataciguat

See all Ataciguat clinical trials

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.